Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected
ObjectiveSepsis is one of the leading causes of the deaths in hospitals. During sepsis, patients are exposed to endotoxemia, which may contribute to the dysregulation of the immune system frequently observed in sepsis. This dysregulation leads to impaired pro-inflammatory responses and may increase...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01133/full |
id |
doaj-845bf62b6bcf4e4bac64637ce6be6359 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alexandra Brinkhoff Alexandra Brinkhoff Annette Sieberichs Annette Sieberichs Harald Engler Sebastian Dolff Sven Benson Johannes Korth Manfred Schedlowski Andreas Kribben Oliver Witzke Benjamin Wilde |
spellingShingle |
Alexandra Brinkhoff Alexandra Brinkhoff Annette Sieberichs Annette Sieberichs Harald Engler Sebastian Dolff Sven Benson Johannes Korth Manfred Schedlowski Andreas Kribben Oliver Witzke Benjamin Wilde Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected Frontiers in Immunology systemic inflammation T-cells IL-17A IFNγ Treg IL-10 |
author_facet |
Alexandra Brinkhoff Alexandra Brinkhoff Annette Sieberichs Annette Sieberichs Harald Engler Sebastian Dolff Sven Benson Johannes Korth Manfred Schedlowski Andreas Kribben Oliver Witzke Benjamin Wilde |
author_sort |
Alexandra Brinkhoff |
title |
Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected |
title_short |
Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected |
title_full |
Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected |
title_fullStr |
Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected |
title_full_unstemmed |
Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected |
title_sort |
pro-inflammatory th1 and th17 cells are suppressed during human experimental endotoxemia whereas anti-inflammatory il-10 producing t-cells are unaffected |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2018-05-01 |
description |
ObjectiveSepsis is one of the leading causes of the deaths in hospitals. During sepsis, patients are exposed to endotoxemia, which may contribute to the dysregulation of the immune system frequently observed in sepsis. This dysregulation leads to impaired pro-inflammatory responses and may increase the risk for secondary infections in sepsis. The experimental human endotoxemia model is widely used as a model system to study the acute effects of endotoxemia. Under physiological circumstances, the immune system is tightly regulated. Effector T-cells exert pro-inflammatory function and are restrained by regulatory T-cells (Tregs), which modulate pro-inflammatory effector responses. Endotoxemia may induce inadequate Treg activity or render effector T-cells dysfunctional. It was the aim of the study to investigate effector T-cell and Treg responses in an experimental human endotoxemia model.MethodsIn a cross-over designed placebo-controlled study, 20 healthy male volunteers received an intravenous injection of either lipopolysaccharide (LPS) (0.8 ng/kg body weight) or a placebo (saline 0.9%). CD3+ T-cells, CD4+ T-cells, CD8+ T-cells, and intracellular cytokine profiles were measured with flow cytometry at baseline and at repeated points after LPS/placebo injection. Complete blood cell counts were obtained with an automated hematology analyzer and cytokines were quantified by ELISA.ResultsCirculating neutrophils were significantly increased 2 h after LPS injection (p < 0.001) while absolute number of CD3+ T-cells, CD4+ T-cells, and CD8+ T-cells decreased (p < 0.001). Effector T-helper-cells (THs) showed a significant—but transient—decrease of pro-inflammatory IFNγ, interleukin (IL)-2, TNFα, and IL-17A production after LPS injection (p < 0.001). In contrast, the frequency of Treg and the capacity to produce IL-10 were unchanged (p = 0.21).ConclusionEffector THs fail to produce pro-inflammatory Th1-/Th17-associated cytokines after LPS challenge. In contrast, IL-10 production by Treg is not affected. Thus, endotoxemia-induced suppression of pro-inflammatory THs might be considered as a contributing factor to immunoparalysis in sepsis. |
topic |
systemic inflammation T-cells IL-17A IFNγ Treg IL-10 |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2018.01133/full |
work_keys_str_mv |
AT alexandrabrinkhoff proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT alexandrabrinkhoff proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT annettesieberichs proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT annettesieberichs proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT haraldengler proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT sebastiandolff proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT svenbenson proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT johanneskorth proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT manfredschedlowski proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT andreaskribben proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT oliverwitzke proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected AT benjaminwilde proinflammatoryth1andth17cellsaresuppressedduringhumanexperimentalendotoxemiawhereasantiinflammatoryil10producingtcellsareunaffected |
_version_ |
1725816035694608384 |
spelling |
doaj-845bf62b6bcf4e4bac64637ce6be63592020-11-24T22:08:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-05-01910.3389/fimmu.2018.01133362638Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are UnaffectedAlexandra Brinkhoff0Alexandra Brinkhoff1Annette Sieberichs2Annette Sieberichs3Harald Engler4Sebastian Dolff5Sven Benson6Johannes Korth7Manfred Schedlowski8Andreas Kribben9Oliver Witzke10Benjamin Wilde11Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyInstitute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, GermanyObjectiveSepsis is one of the leading causes of the deaths in hospitals. During sepsis, patients are exposed to endotoxemia, which may contribute to the dysregulation of the immune system frequently observed in sepsis. This dysregulation leads to impaired pro-inflammatory responses and may increase the risk for secondary infections in sepsis. The experimental human endotoxemia model is widely used as a model system to study the acute effects of endotoxemia. Under physiological circumstances, the immune system is tightly regulated. Effector T-cells exert pro-inflammatory function and are restrained by regulatory T-cells (Tregs), which modulate pro-inflammatory effector responses. Endotoxemia may induce inadequate Treg activity or render effector T-cells dysfunctional. It was the aim of the study to investigate effector T-cell and Treg responses in an experimental human endotoxemia model.MethodsIn a cross-over designed placebo-controlled study, 20 healthy male volunteers received an intravenous injection of either lipopolysaccharide (LPS) (0.8 ng/kg body weight) or a placebo (saline 0.9%). CD3+ T-cells, CD4+ T-cells, CD8+ T-cells, and intracellular cytokine profiles were measured with flow cytometry at baseline and at repeated points after LPS/placebo injection. Complete blood cell counts were obtained with an automated hematology analyzer and cytokines were quantified by ELISA.ResultsCirculating neutrophils were significantly increased 2 h after LPS injection (p < 0.001) while absolute number of CD3+ T-cells, CD4+ T-cells, and CD8+ T-cells decreased (p < 0.001). Effector T-helper-cells (THs) showed a significant—but transient—decrease of pro-inflammatory IFNγ, interleukin (IL)-2, TNFα, and IL-17A production after LPS injection (p < 0.001). In contrast, the frequency of Treg and the capacity to produce IL-10 were unchanged (p = 0.21).ConclusionEffector THs fail to produce pro-inflammatory Th1-/Th17-associated cytokines after LPS challenge. In contrast, IL-10 production by Treg is not affected. Thus, endotoxemia-induced suppression of pro-inflammatory THs might be considered as a contributing factor to immunoparalysis in sepsis.https://www.frontiersin.org/article/10.3389/fimmu.2018.01133/fullsystemic inflammationT-cellsIL-17AIFNγTregIL-10 |